OQRO

Feed News

Explore

Insider trades Fund moves Congressional trades Federal contracts Screener

Yours

Watchlist Alerts Saved Ask Claude or ChatGPT

Create a free account Sign in

OQRO

Search/

Loading…

Officer exercised or converted 1,379 TECH derivative securities | OQRO

Home
Insider trades
Bio-Techne
Officer exercised or converted 1,379 TECH derivative securities

Insider trades

Insider trade

Officer exercised or converted 1,379 TECH derivative securities

Traded Aug 15, 2026 · Filed Aug 18, 2026

TECBio-TechneTECH

1,379
Derivative units

Why it stands out

Derivative exercise or conversion — not an open-market buy.

Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell

View the official recordSEC Form 4 — Statement of Changes in Beneficial Ownership

All the details

Dates, kept separate

Transaction date: Aug 15, 2026
Reporting period: Not applicable
Filed with the SEC: Aug 18, 2026

OfficerOption exercise

Context

Classification

option exercise

Code M — exercise or conversion of a derivative security

Planned / mechanical clue

Footnote references vesting of compensation awards

Only flagged when a footnote says so; never inferred

Source receipt

Record ID: 0000914190-26-000114

Ask Claude or ChatGPT about these filings. Connect OQRO in a minute, then ask things like “which insiders bought this week?”

Filed / recorded

Aug 18, 2026, 8:13 PM UTC

Added to OQRO

Oct 2, 2026, 12:27 PM UTC

Parser

form4-xml-v1

Data quality

Verified: identifiers matched exactly

Issuer

BIO-TECHNE Corp

Issuer CIK

842023

Ticker

TECH

Reporting person

Steven C. Crouse

Relationship

Officer

Officer title

President - Diag & Spatial Bi

Security

Restricted Stock Units

Table

Derivative (Table II)

Transaction date

Aug 15, 2026

Transaction code

Shares / units

1,379

Price per share

$0.00

Acquired / disposed

Disposed (D)

Shares owned after

Ownership form

Direct

Amendment

Footnotes from the filing

Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock.
1,379 restricted stock units vest on 8/15/2026.

Around the same time

Shane BohnenSVP - General Counsel

Filed 7w ago

11KDerivative units

Traded Aug 17 · filed 2 days later

Compensation award — excluded from discretionary-purchase analysis.

More Official record

Shane BohnenSVP - General Counsel

Filed 7w ago

18KDerivative units

Traded Aug 17 · filed 2 days later

Compensation award — excluded from discretionary-purchase analysis.

More Official record

Kim KeldermanChief Executive Officer

Filed 7w ago

58KDerivative units

Traded Aug 17 · filed 2 days later

Compensation award — excluded from discretionary-purchase analysis.

More Official record